182 related articles for article (PubMed ID: 36770857)
1. MOZART, a QSAR Multi-Target Web-Based Tool to Predict Multiple Drug-Enzyme Interactions.
Concu R; Cordeiro MNDS; Pérez-Pérez M; Fdez-Riverola F
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770857
[TBL] [Abstract][Full Text] [Related]
2. NL MIND-BEST: a web server for ligands and proteins discovery--theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum.
González-Díaz H; Prado-Prado F; Sobarzo-Sánchez E; Haddad M; Maurel Chevalley S; Valentin A; Quetin-Leclercq J; Dea-Ayuela MA; Teresa Gomez-Muños M; Munteanu CR; José Torres-Labandeira J; García-Mera X; Tapia RA; Ubeira FM
J Theor Biol; 2011 May; 276(1):229-49. PubMed ID: 21277861
[TBL] [Abstract][Full Text] [Related]
3. 2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins.
Prado-Prado F; García-Mera X; Escobar M; Sobarzo-Sánchez E; Yañez M; Riera-Fernandez P; González-Díaz H
Eur J Med Chem; 2011 Dec; 46(12):5838-51. PubMed ID: 22005185
[TBL] [Abstract][Full Text] [Related]
4. 3D MI-DRAGON: new model for the reconstruction of US FDA drug- target network and theoretical-experimental studies of inhibitors of rasagiline derivatives for AChE.
Prado-Prado F; García-Mera X; Escobar M; Alonso N; Caamaño O; Yañez M; González-Díaz H
Curr Top Med Chem; 2012; 12(16):1843-65. PubMed ID: 23030618
[TBL] [Abstract][Full Text] [Related]
5. Using entropy of drug and protein graphs to predict FDA drug-target network: theoretic-experimental study of MAO inhibitors and hemoglobin peptides from Fasciola hepatica.
Prado-Prado F; García-Mera X; Abeijón P; Alonso N; Caamaño O; Yáñez M; Gárate T; Mezo M; González-Warleta M; Muiño L; Ubeira FM; González-Díaz H
Eur J Med Chem; 2011 Apr; 46(4):1074-94. PubMed ID: 21315497
[TBL] [Abstract][Full Text] [Related]
6. ADis-QSAR: a machine learning model based on biological activity differences of compounds.
Park GJ; Kang NS
J Comput Aided Mol Des; 2023 Sep; 37(9):435-451. PubMed ID: 37382799
[TBL] [Abstract][Full Text] [Related]
7. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
8. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
[TBL] [Abstract][Full Text] [Related]
9. Predicting drugs and proteins in parasite infections with topological indices of complex networks: theoretical backgrounds, applications, and legal issues.
González-Díaz H; Romaris F; Duardo-Sanchez A; Pérez-Montoto LG; Prado-Prado F; Patlewicz G; Ubeira FM
Curr Pharm Des; 2010; 16(24):2737-64. PubMed ID: 20642428
[TBL] [Abstract][Full Text] [Related]
10. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Prado-Prado FJ; Martinez de la Vega O; Uriarte E; Ubeira FM; Chou KC; González-Díaz H
Bioorg Med Chem; 2009 Jan; 17(2):569-75. PubMed ID: 19112024
[TBL] [Abstract][Full Text] [Related]
11. Targeting HIV/HCV Coinfection Using a Machine Learning-Based Multiple Quantitative Structure-Activity Relationships (Multiple QSAR) Method.
Wei Y; Li W; Du T; Hong Z; Lin J
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336592
[TBL] [Abstract][Full Text] [Related]
12. Multi-target spectral moments for QSAR and Complex Networks study of antibacterial drugs.
Prado-Prado FJ; Uriarte E; Borges F; González-Díaz H
Eur J Med Chem; 2009 Nov; 44(11):4516-21. PubMed ID: 19631422
[TBL] [Abstract][Full Text] [Related]
13. In Silico Study of In Vitro GPCR Assays by QSAR Modeling.
Mansouri K; Judson RS
Methods Mol Biol; 2016; 1425():361-81. PubMed ID: 27311474
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of multi-target deep neural network models for compound potency prediction under increasingly challenging test conditions.
Rodríguez-Pérez R; Bajorath J
J Comput Aided Mol Des; 2021 Mar; 35(3):285-295. PubMed ID: 33598870
[TBL] [Abstract][Full Text] [Related]
15. Multi-task learning models for predicting active compounds.
Zhao Z; Qin J; Gou Z; Zhang Y; Yang Y
J Biomed Inform; 2020 Aug; 108():103484. PubMed ID: 32615159
[TBL] [Abstract][Full Text] [Related]
16. Machine learning models for predicting the activity of AChE and BACE1 dual inhibitors for the treatment of Alzheimer's disease.
Dhamodharan G; Mohan CG
Mol Divers; 2022 Jun; 26(3):1501-1517. PubMed ID: 34327619
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Structure Activity/Toxicity Relationship through Neural Networks for Drug Discovery or Regulatory Use.
Novič M
Curr Top Med Chem; 2023; 23(29):2792-2804. PubMed ID: 37867278
[TBL] [Abstract][Full Text] [Related]
18. Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Prado-Prado FJ; García-Mera X; González-Díaz H
Bioorg Med Chem; 2010 Mar; 18(6):2225-2231. PubMed ID: 20185316
[TBL] [Abstract][Full Text] [Related]
19. Mapping chemical structure-activity information of HAART-drug cocktails over complex networks of AIDS epidemiology and socioeconomic data of U.S. counties.
Herrera-Ibatá DM; Pazos A; Orbegozo-Medina RA; Romero-Durán FJ; González-Díaz H
Biosystems; 2015 Jun; 132-133():20-34. PubMed ID: 25916548
[TBL] [Abstract][Full Text] [Related]
20. [Quantitative structure-activity relationship model for prediction of cardiotoxicity of chemical components in traditional Chinese medicines].
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 49(3):551-556. PubMed ID: 28628163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
